MINNEAPOLIS--(BUSINESS WIRE)--Vergent Bioscience, a clinical-stage biotechnology company developing tumor-targeted imaging agents, announced that the U.S. Food & Drug Administration (FDA) has granted ...
Abenacianine, a fluorescent imaging agent, aids in real-time tumor visualization during lung cancer surgeries, enhancing surgical precision and outcomes. Fast track designation by the FDA highlights ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results